SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis

This investigation was aimed at disclosing whether SRPX2 affected pancreatic cancer (PC) chemoresistance by regulating PI3K/Akt/mTOR signaling.

Bibliographic Details
Main Authors:	Gao Zhenyuan, Wu Jisong, Wu Xiao, Zheng Jialei, Ou Yimei
Format:	Article
Language:	English
Published:	De Gruyter 2020-10-01
Series:	Open Medicine
Subjects:	srpx2 pi3k/akt/mtor pancreatic cancer chemo-resistance cell migration cell invasion
Online Access:	https://doi.org/10.1515/med-2020-0157

Internet

https://doi.org/10.1515/med-2020-0157